European Archives - Page 1176 of 1617 - European Medical Journal

Predicting an Epidemic? Evolution Must be Considered

SCIENTISTS using mathematical models to predict the spread of disease across populations must consider evolutionary changes…

An interview with Prof Paul Fockens at UEG Week Barcelona 2019

We spoke to Prof Paul Fockens (UEG President) at UEG Week 2019, Barcelona, Spain…

How a ‘Portable’ Intervention (Deep Diaphragmatic Breathing) Could Help Clinicians in the Time of Stress Related to the COVID-19 Pandemic

At a time of uncertainty and fear during the COVID-19 pandemic, medical practitioners experience major unexpected changes in the…

“We need to get better at putting the patient at the centre of what we do”

At the time, I was a consultant at the university hospital in Heidelberg and I was offered the opportunity to work in a new area for a…

Linking Clinicians with Suppliers to Address the COVID-19 Medical Equipment Shortag

Linking Clinicians with Suppliers to Address the COVID-19 Medical Equipment Shortage

EMG-Health is proud to announce the launch of our brand new web-based service connecting clinicians in need of equipment…

Ability to Stabilise and Stockpile Covid-19 Vaccine is Vital

An incredible global effort is underway by companies and scientists digging deep to find a vaccine for Covid-19…

New COVID-19 Vaccine Candidate Generates Neutralising Antibodies

New COVID-19 Vaccine Candidate Generates Neutralising Antibodies

A VACCINE candidate for COVID-19 has shown promise in mice studies by producing antibodies specific to SARS-CoV-2, at levels thought to be sufficient…

Could Ivermectin be an Effective COVID-19 Treatment?

Could Ivermectin be an Effective COVID-19 Treatment?

IVERMECTIN, an antiparasitic drug that is in use around the world, has shown to kill the SARS-CoV-2 virus within 48 hours…

Erythroderma: A Manifestation of Cutaneous and Systemic Diseases

Erythroderma, or generalised exfoliative dermatitis, is a rare inflammatory disorder characterised by generalised erythema, involving more than 90%…

Second AACR International Meeting: Advances in Malignant Lymphoma

Second AACR International Meeting: Advances in Malignant Lymphoma: Maximizing the Basic-Translational Interface for Clinical Application held in…